Arkolith/Insider Trading/AXSM/Form 4

Tabuteau Herriot

Chief Executive Officer, Director, 10% OwnerAxsome Therapeutics, Inc. (AXSM) · full profile →Form 4 · filed Dec 4, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$11.6M
Net Open-Market Flow
-$11.6M
Transactions
9
6 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 4, 2025Option exercise(M)11K$8.02$85K18K
Dec 4, 2025Sell(S)11K$148.18$1.6M7K
Dec 3, 2025Option exercise(M)20K$8.02$162K27K
Dec 3, 2025Sell(S)20K$146.94$3.0M7K
Dec 2, 2025Option exercise(M)49K$8.02$395K56K
Dec 2, 2025Sell(S)49K$144.59$7.1M7K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 4, 2025Option exercise(M)11K—$0172K
Dec 3, 2025Option exercise(M)20K—$0182K
Dec 2, 2025Option exercise(M)49K—$0203K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-308354) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML